Mon.Jun 09, 2025

article thumbnail

It’s Time to Admit: In an Era of High Distrust, Pharma DTC TV Ads Are Ineffective

World of DTC Marketing

For decades, pharma companies have relied on direct-to-consumer (DTC) television ads to build awareness and drive demand for prescription drugs. However, as the healthcare landscape continues to evolve—and trust in institutions declines—it’s time for the industry to confront a hard truth: DTC TV ads are no longer as effective as they once were. They may be increasingly out of step with how patients make healthcare decisions today.

Pharma 222
article thumbnail

Fierce Pharma - Untitled Article

Fierce Pharma

The FDA has blessed Merck’s clesrovimab to protect against lower respiratory tract disease related to respiratory syncytial virus in newborns and infants. The monoclonal antibody, which will be known commercially as Enflonsia, will challenge Sanofi and AstraZeneca’s blockbuster Beyfortus.

FDA 198
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Metsera’s Amylin Drug Looks Good in Phase 1, Shows Potential to be a Once-Monthly Obesity Med

MedCity News

Novo Nordisk, AbbVie, and Roche each have weekly injectable drug candidates designed to bind to and activate the amylin receptor to trigger weight loss. Metsera’s contender, MET-233i, is designed with technology that enables longer dosing intervals and the company is proceeding with development of this engineered peptide as a monotherapy and as part of a drug combination.

article thumbnail

Fierce Pharma - Untitled Article

Fierce Pharma

The drug is the first triple-combo pill for the initial treatment of hypertension in the U.S.

225
225
article thumbnail

State of AI in Sales & Marketing 2025

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

article thumbnail

The Hidden Frontline of Public Health: How EMS Data Is Powering a New Era of Syndromic Surveillance 

MedCity News

EMS data is often the earliest signal of a looming public health crisis. By tapping into it in real time, agencies can detect overdose spikes, respiratory surges, or behavioral health trends days before traditional systems catch up. The post The Hidden Frontline of Public Health: How EMS Data Is Powering a New Era of Syndromic Surveillance appeared first on MedCity News.

270
270

More Trending

article thumbnail

Navina’s AI Copilot Eases the Value-Based Burden, Study Shows

MedCity News

[Sponsored] A new independent study from Phyx Primary Care’s Innovation Lab points to measurable improvements in physician burnout, documentation efficiency, and key VBC metrics among primary care practices. The post Navina’s AI Copilot Eases the Value-Based Burden, Study Shows appeared first on MedCity News.

article thumbnail

Fierce Pharma - Untitled Article

Fierce Pharma

One day before the potential FDA approval of a rival respiratory syncytial virus monoclonal antibody from Merck, Sanofi has revealed an aggressive supply effort for its RSV blockbuster Beyfortus, including a plan to begin shipping its AstraZeneca-partnered shot early in the third quarter.

FDA 179
article thumbnail

The biggest obesity deals of 2025 so far

PharmaVoice

Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve

Pharma 147
article thumbnail

Whole Eye Transplantation is No Longer Just Science Fiction

MedCity News

The technologies and techniques developed for eye transplantation and nerve regeneration may have significant translational potential for other biomedical needs including: spinal cord injury, central nervous system regeneration, retinal cell and tissue transplantation, and other forms of organ and tissue transplantation. The post Whole Eye Transplantation is No Longer Just Science Fiction appeared first on MedCity News.

200
200
article thumbnail

The Intersection of AI and Sales: Personalization Without Compromise

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

article thumbnail

Fierce Pharma - Untitled Article

Fierce Pharma

The Department of Health and Human Services has removed all 17 sitting members of the CDC's Advisory Committee on Immunization Practices.

238
238
article thumbnail

GoodRx Unveils Cost-Plus Model for Independent Pharmacies

MedCity News

GoodRx launched Community Link, a new cost-plus pricing program that allows independent pharmacies to contract directly with GoodRx. The post GoodRx Unveils Cost-Plus Model for Independent Pharmacies appeared first on MedCity News.

147
147
article thumbnail

The Best Medical Sales Jobs You Should Know

Evolve Your Success

Why Medical Sales Is a Career Worth Exploring Medical sales isn’t just a job, it’s one of the most dynamic, financially rewarding, and purpose-driven careers in healthcare. Whether you’re a recent grad, a healthcare provider ready to pivot, or a seasoned sales pro looking for a challenge, there’s a role for you. In this bold new era of healthcare and medical sales, demand is high, innovation is constant, and opportunities are everywhere. 1.

article thumbnail

Harnessing Real-World Data and AI to Advance Research and Treatment for Benign Prostatic Hyperplasia

MedCity News

The ability to harness real-world insights at scale empowers life sciences companies and clinicians to develop more targeted therapies, improve patient outcomes, and drive evidence-based innovation in BPH treatment. The post Harnessing Real-World Data and AI to Advance Research and Treatment for Benign Prostatic Hyperplasia appeared first on MedCity News.

Patients 165
article thumbnail

The GTM Intelligence Era: ZoomInfo 2025 Customer Impact Report

ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!

article thumbnail

Novo Nordisk obesity drug linked to rare cause of sight loss

pharmaphorum

The EMA has become the first regulator to link the use of Novo Nordisk's GLP-1 agonist semaglutide with sight-robbing disorder NAION

113
113
article thumbnail

Merck RSV Drug for Infants Wins FDA Nod, But CDC Committee That Will Advise on Its Use Is Gutted

MedCity News

FDA approval of Merck’s RSV antibody drug, Enflonsia, makes it a direct competitor to Sanofi’s Beyfortus. The new Merck product is expected to be discussed by the CDC’s Advisory Committee on Immunization Practices; ACIP will have an entirely new roster at its next meeting after all 17 sitting members were dismissed by Health and Human Services Secretary Robert F.

FDA 191
article thumbnail

EC approves AstraZeneca’s acalabrutinib combo for CLL

Pharmaceutical Technology

The EC has granted approval for a fixed-duration regimen of AstraZeneca's Calquence (acalabrutinib) plus venetoclax.

76
article thumbnail

Multi-billion-pound funding to accelerate UK’s high-growth sectors

European Pharmaceutical Review

The UK Government is set to announce an investment of £86 billion in next week’s Spending Review, aimed at boosting the country’s highest growth sectors, such as life sciences. The review will specify how the government is planning to invest in Britain’s renewal, which helps to drive its Plan for Change. This commitment will support a broad range of sectors, including advanced manufacturing.

article thumbnail

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

article thumbnail

The European Market Access Lag: 2021–2024

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

article thumbnail

Bridging the Gap Between Strategy and Practice in IDN Partnerships

Pharmaceutical Commerce

In order to succeed in today’s outcomes-driven healthcare landscape, pharmaceutical companies must move from traditional sales models to strategic, measurable partnerships with integrated delivery networks (IDNs).

article thumbnail

FDA approves YolTech’s YOLT-101 for familial hypercholesterolemia

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

FDA 52
article thumbnail

Understanding Market Share and Its Importance 

Cesare Ferrari

Market share is a critical metric that pharmaceutical and medical device companies use to gauge commercial success and enhance business profitability. Despite its significance, many companies, particularly small and medium-sized medical device firms, do not attempt to calculate it. Additionally, I find it surprising that many marketing professionals overlook the opportunity to leverage this metric and its components for market analysis and strategic planning.

article thumbnail

5 Ways You Can Win Faster with Gen AI in Sales

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

article thumbnail

Aytu BioPharma to commercialise Exxua for MDD in the US

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

article thumbnail

Ask The Chefs: What Did You Take Away from SSP’s 2025 Annual Meeting?

Copyright Clearance Center

The Scholarly Kitchen What’s Hot and Cooking In Scholarly Publishing About Archives Collections Scholarly Publishing 101 -- The Basics Collections Scholarly Publishing 101 -- The Basics Academia Business Models Discovery and Access Diversity, Equity, Inclusion, and Accessibility Economics Libraries Marketing Mental Health Awareness Metrics and Analytics Open Access Organizational Management Peer Review Strategic Planning Technology and Disruption Translations Translations All Translations Chines

Ethics 69
article thumbnail

NHS set for £30bn boost in spending review

pharmaphorum

The NHS is said to be in line for a £30bn increase to its budget in the upcoming spending review, but some are concerned it will not be enough

101
101
article thumbnail

Podcast: AI and Supervised Machine Learning in Clinical Trials – Part 2

Pharmaceutical Technology

In episode two of The Zelta Podcast, we continue our conversation about AI and supervised machine learning in clinical trials…

52
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

George gets FDA nod for first blood pressure triple therapy

pharmaphorum

George Medicines' Widaplik can address key challenges in current hypertension treatment, according to the UK drugmaker's CEO

article thumbnail

American Society of Clinical Oncology (ASCO) Annual Meeting 2025

Pharmaceutical Technology

The American Society of Clinical Oncology (ASCO) Annual Meeting 2025, held from 30 May to 3 June, in Chicago, Illinois,…

52
article thumbnail

Pharma Pulse 6/9/25: Accelerating Site Activation and Recruitment with MCRC Partnerships; Avenzo Begins Phase I/II Trial of CDK4 Selective Inhibitor for Breast Cancer

Pharmaceutical Commerce

Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking approved drugs to market.